Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

524

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2017

Study Completion Date

November 15, 2021

Conditions
Large B Cell Lymphoma
Interventions
BIOLOGICAL

rituximab

IV

DRUG

cyclophosphamide

IV

DRUG

doxorubicin

IV or CIVI

DRUG

vincristine

IV or CIVI

DRUG

prednisone

oral

DRUG

etoposide

CIVI

DRUG

filgrastim

IV

DRUG

pegfilgrastim

IV

Trial Locations (47)

10021

New York Weill Cornell Cancer Center at Cornell University, New York

12801

Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

18042

Easton Regional Cancer Center at Easton Hospital, Easton

18201

Geisinger Hazleton Cancer Center, Hazleton

18711

Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre

19713

CCOP - Christiana Care Health Services, Newark

21215

Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore

26506

Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown

28501

Kinston Medical Specialists, Kinston

28677

Iredell Memorial Hospital, Statesville

44708

Mercy Cancer Center at Mercy Medical Center, Canton

48075

Providence Cancer Institute at Providence Hospital - Southfield Campus, Southfield

54449

Marshfield Clinic - Marshfield Center, Marshfield

Saint Joseph's Hospital, Marshfield

54476

Marshfield Clinic - Weston Center, Weston

54481

Marshfield Clinic at Saint Michael's Hospital, Stevens Point

Saint Michael's Hospital Cancer Center, Stevens Point

54501

Ministry Medical Group at Saint Mary's Hospital, Rhinelander

54548

Marshfield Clinic - Lakeland Center, Minocqua

54868

Marshfield Clinic - Indianhead Center, Rice Lake

58201

Altru Cancer Center at Altru Hospital, Grand Forks

60153

Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood

60657

Creticos Cancer Center at Advocate Illinois Masonic Medical Center, Chicago

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

63136

Christian Hospital Northeast-Northwest, St Louis

92134

Naval Medical Center - San Diego, San Diego

94040

Camino Medical Group - Treatment Center, Mountain View

94301

Palo Alto Medical Foundation, Palo Alto

94574

Saint Helena Hospital, St. Helena

98431

Madigan Army Medical Center - Tacoma, Tacoma

92093-0658

Rebecca and John Moores UCSD Cancer Center, La Jolla

06360

Eastern Connecticut Hematology and Oncology Associates, Norwich

60611-3013

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

60612-7243

University of Illinois Cancer Center, Chicago

20889-5600

National Naval Medical Center, Bethesda

20892-1182

NIH - Warren Grant Magnuson Clinical Center, Bethesda

03301

New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord

03106

New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett

28233-3549

Presbyterian Cancer Center at Presbyterian Hospital, Charlotte

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus

17822-0001

Geisinger Cancer Institute at Geisinger Health, Danville

17033-0850

Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey

15224-1791

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh

05602

Mountainview Medical, Berlin Corners

23298-0037

Virginia Commonwealth University Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00118209 - Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter